Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Protein A Resin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
The Global Protein A Resin Market has exhibited a robust growth trajectory, with an impressive compound annual growth rate (CAGR) of 9.91% forecast from 2023 to 2029. A crucial component in biopharmaceutical manufacturing, Protein A Resin is indispensable in the purification of monoclonal antibodies and other proteins.
Technological advancements play a pivotal role in the market's expansion. With improved binding capacities, enhanced selectivity, and increased stability, next-generation protein A resins fortify the production capabilities of biopharmaceutical companies. The growing adoption of single-use technologies further contributes to this positive outlook, offering reduced cross-contamination risks and operational flexibility. These advancements are anticipated to be critical drivers of market growth.
Geographically, North America maintains a dominant market position due to its strong biopharmaceutical industry and advanced healthcare infrastructure. The region's commitment to high-quality biopharmaceutical production, underpinned by rigorous regulatory standards, ensures consistent demand for high-performance protein A resins.
Healthcare Concerns Escalate Demand
The rising prevalence of chronic diseases globally has sparked urgent demand for novel therapeutic options, particularly biopharmaceuticals. This surge in demand has, in turn, led to an increased requirement for Protein A Resin in the purification process for these therapies, emphasizing its integral role in meeting current medical needs.
Challenges and Opportunities
Despite the robust growth, the market faces challenges, such as capacity constraints due to the immense demand for Protein A Resin and competition from alternative purification technologies. Nevertheless, opportunities manifest in the rising demand for biosimilars and the expansion of the biopharmaceutical sector, with specific growth anticipated in the agarose-based matrix type and among biopharmaceutical manufacturers as end users. Regional
Key Attributes
| Report Attribute | Details |
| No. of Pages | 179 |
| Forecast Period | 2023-2029 |
| Estimated Market Value (USD) in 2023 | $1.32 Billion |
| Forecasted Market Value (USD) by 2029 | $2.33 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- GE Healthcare Inc.
- Merck Millipore
- PerkinElmer, Inc.
- GenScript Biotech Corp.
- Agilent Technologies
- Repligen Corp.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Abcam PLC
- Novasep Holdings SAS
For more information about this report visit https://www.researchandmarkets.com/r/1tpunp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
